scispace - formally typeset
Open AccessJournal ArticleDOI

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy

TLDR
Electrical dyssynchrony, as measured by QLV, was strongly and independently associated with reverse remodelling and QOL with CRT, and acute measurements of QLV may be useful to guide LV lead placement.
Abstract
Aims The aim of the present study was to evaluate the relationship between left ventricular (LV) electrical delay, as measured by the QLV interval, and outcomes in a prospectively designed substudy of the SMART-AV Trial. Methods and results This was a multicentre study of patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) defibrillator implantation. In 426 subjects, QLV was measured as the interval from the onset of the QRS from the surface ECG to the first large peak of the LV electrogram. Left ventricular volumes were measured by echocardiography at baseline and after 6 months of CRT by a blinded core laboratory. Quality of life (QOL) was assessed by a standardized questionnaire. When separated by quartiles based on QLV duration, reverse remodelling response rates (>15% reduction in LV end systolic volume) increased progressively from 38.7 to 68.4% and QOL response rate (>10 points reduction) increased from 50 to 72%. Patients in the highest quartile of QLV had a 3.21-fold increase (1.58–6.50, P = 0.001) in their odds of a reverse remodelling response after correcting for QRS duration, bundle branch block type, and clinical characteristics by multivariate logistic regression analysis. Conclusion Electrical dyssynchrony, as measured by QLV, was strongly and independently associated with reverse remodelling and QOL with CRT. Acute measurements of QLV may be useful to guide LV lead placement.

read more

Citations
More filters
Journal ArticleDOI

Avoiding non-responders to cardiac resynchronization therapy: a practical guide

TL;DR: The prevention of NR to CRT is essential to improve the overall performance of this treatment and lower its risk-benefit ratio, and precise recommendations are offered regarding the optimal device programming, use of telemonitoring and optimization of management of HF.
Journal ArticleDOI

Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy.

TL;DR: The main findings were that REVERSE showed significant reverse remodeling, MADIT-CRT showed less hospitalization, and RAFT also showed significant reduction in mortality in the CRT arm.
Journal ArticleDOI

Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy Results From the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT)

TL;DR: The data do not support the use of implantable cardioverter defibrillator-CRT in patients with non-LBBB, especially when the QRS duration is <160 ms, but there may be some delayed benefit when theQRS is ≥160ms, but this needs further investigation.
References
More filters
Journal ArticleDOI

The effect of cardiac resynchronization on morbidity and mortality in heart failure

TL;DR: Cardiac resynchronization has been shown to reduce symptoms and improve left ventricular function in patients with heart failure due to systolic dysfunction and cardiac dyssynchrony.
Journal ArticleDOI

Cardiac-resynchronization therapy for the prevention of heart-failure events.

TL;DR: CRT combined with ICD decreased the risk of heart-failure events in relatively asymptomatic patients with a low ejection fraction and wide QRS complex and was associated with a significant reduction in left ventricular volumes and improvement in the ejectedion fraction.
Related Papers (5)